BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain
NCT ID: NCT01186341
Last Updated: 2023-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
418 participants
OBSERVATIONAL
2009-06-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Meditation Utilizing Signals From Electroencephalography in Chronic Pain (MUSE-PAIN) Study
NCT04944459
Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)
NCT07094282
Back Pain Response to Different Acupuncture Methods
NCT01598974
Multi-modal Imaging of Myofascial Pain
NCT06036524
A Neurofeedback Treatment for Chronic Musculoskeletal Pain
NCT03863847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Little is known about the health outcomes of patients who present to an IM center and undergo a variety of treatment modalities to treat a specific condition. Adequately capturing and describing IM patient outcomes is a challenge for many reasons. First, given the whole person focus of IM, multiple domains of outcomes must be considered including physical, psychological, social, and spiritual. Second, since the patient-centric notion of individualized care is seminal to IM, IM outcomes must allow for patient-reported outcomes. Finally, the complexity of whole system care creates a natural barrier when measuring IM efficacy. Whole systems of care theoretically rely on synergistic and inseparable components and conceptualize the patient-practitioner interaction as a key component of care.
The Bravewell Integrative Medicine Research Network (BraveNet) is a practice-based research network of nine leading integrative medicine centers around the U.S. collaborating in clinical outcomes research to increase the knowledge and evidence-base of IM. These centers may differ in terms of patient population, medical conditions seen, IM services offered, and treatment outcomes, but all are committed to the provision of integrative care.
Preliminary results from an ongoing cross-sectional survey of nine of the BraveNet Outpatient Clinics indicate that pain was the leading reason for patient visits. As a precursor to a large multi-site clinical trial, this study aims to determine the feasibility of collecting outcomes data on integrative treatment for pain. These preliminary data will also provide an estimation of effect size for powering the multi-site clinical trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Pain
New or existing patients of the center who are seeking their initial treatment at the Integrative Medicine center for chronic pain (chronic \> 3 months) who report their average pain level over the past month to be at least a 4 of 10 on the Visual Analog Scale.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient Status: Participants are eligible if they are new or existing patients of the center who are seeking their initial treatment at the Integrative Medicine center for chronic pain (chronic \> 3 months) who report their average pain level over the past month to be at least a 4 of 10 on the VAS.
* English or Spanish Literacy: Ability to read and write English or Spanish as confirmed by the site personnel and ability to provide informed consent.
* Subject must provide written informed consent before initiation of any study-related procedures.
* Subject must be able to understand and comply with the requirements of the study, as judged by the investigator.
Exclusion Criteria
* Inability to read and write in English or Spanish.
* Any condition which could interfere with, or the treatment for which might interfere with, the conduct of the study or which would, in the opinion of the Investigator, unacceptably increase the patients risk by participating in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Bravewell Collaborative
OTHER
Alliance Institute for Integrative Medicine
OTHER
Allina Health System
OTHER
University of Maryland
OTHER
Beth Israel Medical Center
OTHER
Thomas Jefferson University
OTHER
University of California, San Francisco
OTHER
Scripps Clinic
OTHER
Venice Family Clinic
OTHER
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rowena Dolor, MD
Role: PRINCIPAL_INVESTIGATOR
Duke Clinical Research Institute
Ruth Wolever, PhD
Role: PRINCIPAL_INVESTIGATOR
Duke Integrative Medicine Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scripps Center for Integrative Medicine
La Jolla, California, United States
UCSF Osher Center for Integrative Medicine
San Francisco, California, United States
Venice Family Clinic Simms/Mann Health and Wellness Center
Santa Monica, California, United States
University of Maryland Center for Integrative Medicine
Baltimore, Maryland, United States
Penny George Institute for Health and Healing
Minneapolis, Minnesota, United States
The Continuum Center for Health and Healing
New York, New York, United States
Duke Integrative Medicine
Durham, North Carolina, United States
Alliance Center for Integrative Medicine
Cincinnati, Ohio, United States
Jefferson-Myrna Brind Center of Integrative Medicine
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Abrams DI, Dolor R, Roberts R, Pechura C, Dusek J, Amoils S, Amoils S, Barrows K, Edman JS, Frye J, Guarneri E, Kligler B, Monti D, Spar M, Wolever RQ. The BraveNet prospective observational study on integrative medicine treatment approaches for pain. BMC Complement Altern Med. 2013 Jun 24;13:146. doi: 10.1186/1472-6882-13-146.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00018346
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.